恶性瘤的表谱签名:RNA修饰如何塑造乳腺和卵巢瘤进展
Pankaj Garg1, Ravi Salgia2, Sharad S Singhal2
1Department of Chemistry, GLA University, NH-19, Mathura-Delhi Road, Mathura, Uttar Pradesh 281406, India.
Biochemical pharmacology
|March 10, 2026
概括
经转录组学,即对RNA修饰的研究,为乳腺癌和卵巢癌提供了新的见解. 针对这些RNA变化显示出在瘤学中新型诊断和治疗的前景.
科学领域:
- 瘤学和分子生物学
- 史诗转录组学 史诗转录组学
- 癌症研究 癌症研究
背景情况:
- 乳腺癌和卵巢癌是女性癌症死亡的主要原因,通常是晚期被诊断出高复发率和耐治疗性.
- 经转录学研究可逆RNA化学修饰,如m6A,m5C,Psi和m1A,揭示了新的癌症调节机制.
- 这些修改影响RNA稳定性,拼接,局部化和翻译,影响瘤信号传递,免疫逃避和耐药性.
研究的目的:
- 审查表皮转录学修饰在乳腺和卵巢癌生物学中的作用.
- 突出针对癌症治疗的RNA修饰酶的潜力.
- 讨论RNA修饰模式作为诊断和预后生物标志物的新兴作用.
主要方法:
- 关于癌症中的表体转录组学现有文献的综述.
- 在瘤生物学中分析RNA修饰模式.
- 针对RNA修饰酶的治疗策略的探索.
- 多omics数据,人工智能和个性化医疗的整合.
主要成果:
- RNA'写'器','擦'器和'读'器的失调促进了瘤的扩散,EMT,血管生成和转移.
- 小分子抑制剂,基于CRISPR的编辑和纳米技术显示了向RNA修饰酶的潜力.
- RNA修饰模式正在成为液体活检和精确瘤学的有价值生物标志物.
结论:
- 解码表体转录组签名可以改变对乳腺癌和卵巢癌瘤生物学的理解.
- 针对表观转录学变化的治疗为诊断,预后和个性化治疗提供了新的途径.
- 这一领域代表了以患者为中心的瘤学的新时代,将表体转录学与多体组学和AI整合在一起.
关键词:
乳腺癌是什么? 乳腺癌是什么?史诗转录组学 史诗转录组学卵巢癌是发生在卵巢中的癌症.伪氨酸是一种伪氨酸.基因组RNA的修改 基因组RNA的改变治疗耐药性 治疗耐药性m5C 在线观看m6A 一个很好的.更多相关视频
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
8.0K
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
7.3K
相关概念视频
Tumor Progression
7.7K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.7K
mTOR Signaling and Cancer Progression
1.6K
1.6K
mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
lncRNA - Long Non-coding RNAs
10.1K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
MicroRNAs
4.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs
24.5K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
